leukemia/phosphatase

Le lien est enregistré dans le presse-papiers

Choisissez le type de tri

10 résultats

Magnetic Resonance Imaging:A Window to Anthracycline Toxicity

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

This is a pilot study with a descriptive study design. Anthracycline induced late onset cardiotoxicity, defined in terms of abnormal findings on echocardiography, has been reported to occur in 57% of childhood cancer survivors. Serial monitoring of cardiac function by means of echocardiography

ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Study Rationale 1. AML is a bone marrow based malignancy that is rapidly growing and rapidly fatal if left untreated. Despite therapeutic strategies for up to 70% of patients, 20% are primarily refractory and another 50% will relapse after first line therapy. Among these refractory and relapsed

Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Patients with PSC often have ongoing inflammation and fibrosis (scars) along the length of their bile ducts, and eventually this involves the liver itself which can lead to cirrhosis (severe scarring), severe infections (cholangitis), bile duct cancer and death. Although many patients are treated

Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

PRIMARY OBJECTIVES: I. To determine the maximum tolerated dose (MTD) of bortezomib in combination with midostaurin and intensive chemotherapy in patients with relapsed/refractory acute myeloid leukemia (AML). II. To define the specific toxicities and the dose limiting toxicity (DLT) of midostaurin

Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML)

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

1. INDUCTION CHEMOTHERAPY - For patients randomized to receive Idarubicin (Arm I, AI regimen) will be given Cytarabine 200 mg/m2/day by continuous iv infusion over 24 hours daily for 7 days (D 1-7) along with Idarubicin 12 mg/m2/day iv daily for 3 days (D 1-3). - For patients randomized to receive

Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

PRIMARY OBJECTIVES: I. To investigate the association of common single nucleotide polymorphisms (SNPs) and haplotypes of the three multidrug resistance (MDR) genes with treatment outcome in the clinical studies. II. To assess the effect of ATP-binding cassette (ABC) B1, ABCC1, and ABCG2

Combination of Hydroxyurea and Verapamil for Refractory Meningiomas

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

The investigators have demonstrated previously that the calcium channel antagonists (CCAs) verapamil, nifedipine, and diltiazem can block in vitro and in vivo meningioma growth at clinically relevant doses (Jensen, Lee et al. 1995; Jensen, Petr et al. 2000; Jensen and Wurster 2001). However, only

Safety and Efficacy of Iron Reduction by Phlebotomy

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Background Hematopoietic stem cell transplantation (HSCT) is increasingly used as a treatment for a variety of malignant and non-malignant conditions. With improvements in conditioning regimens and post-transplant care, more HSCT recipients are becoming long-term survivors and therefore increasing

Therapy for Chronic Cold Agglutinin Disease

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

1. Background Chronic cold agglutinin disease (CAD) is mediated by monoclonal cold-reactive autoantibodies that bind to erythrocyte surface antigens, causing haemagglutination and complement-mediated haemolysis. Anaemia is severe (Hb 8.0 g/dL or lower) in one-third of patients and complement-induced

Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

PRIMARY OBJECTIVE: I. To estimate the proportion of patients with previously-untreated chronic phase chronic myelogenous leukemia (CML) attaining major molecular response by 12 months of treatment with dasatinib. SECONDARY OBJECTIVES: I. To estimate the proportion of patients with Philadelphia

Rejoignez notre
page facebook

Herbal & Natural Medicine

La base de données d'herbes médicinales la plus complète soutenue par la science

Fonctionne en 55 langues
Cures à base de plantes soutenues par la science
Reconnaissance des herbes par image
Carte GPS interactive - étiquetez les herbes sur place (à venir)
Lisez les publications scientifiques liées à votre recherche
Rechercher les herbes médicinales par leurs effets
Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées